It is a triple agonist, targeting three hormone receptors simultaneously: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
They handle more niche and complex peptide work, operating somewhat separately from the flagship entity but benefiting from the same infrastructure and regulatory framework
Until recently, it read mostly like a list of digestive complaints -stomachaches, constipation - generally unpleasant but tolerable and rarely severe
L.NorhaizanM
Changes in body composition typically become apparent after 3-6 months of consistent therapy
It maintains physiological hemostasis, prevents non-hemostatic thrombus formation, facilitates wound healing, and regulates inflammation on the endothelial cell surface [95]